Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21.0Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-6.0
Enterprise Value $M4.8EPS (TTM) $-1.1Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio6.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %18.6Current Ratio6.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-83.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-99.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONCS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ONCS is held by these investors:



ONCS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mohan-Peterson SheelaChief Legal&Compliance Officer 2017-07-31Buy3,000$0.8812.5view
DHILLON PUNITPresident and CEO 2017-07-31Buy3,000$0.8812.5view
Mohan-Peterson SheelaChief Legal&Compliance Officer 2017-01-31Buy3,000$0.990view
DHILLON PUNITPresident and CEO 2017-01-31Buy3,000$0.990view
DHILLON PUNITPresident and CEO 2016-07-31Buy3,000$1.44-31.25view
Mohan-Peterson SheelaCL&CO 2016-07-31Buy3,000$1.44-31.25view
DHILLON AVTAR SDirector 2015-10-16Buy10,000$4.36-77.29view
Mohan-Peterson SheelaChief Legal Officer 2015-10-16Buy520$4.24-76.65view
DHILLON PUNITPresident and CEO 2015-10-16Buy10,000$4.25-76.71view
SLANSKY RICHARD BCFO 2015-07-06Buy150,000$6.12-83.82view

Press Releases about ONCS :

Quarterly/Annual Reports about ONCS:

News about ONCS:

Articles On GuruFocus.com
OncoSec Seeks Accelerated Approval to Treat Melanoma Sep 11 2017 
OncoSec Appoints Industry Leader Daniel J. O'Connor to its Board of Directors Sep 07 2017 
OncoSec Announces Presentations at Upcoming Investment and Scientific Conferences Sep 06 2017 
OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors Sep 05 2017 
OncoSec Announces Technology Access Program Agreement with Jounce Therapeutics, Inc. Jun 12 2017 
OncoSec Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Unresectable Metastat Jun 08 2017 
OncoSec to Present at LD Micro Invitational Jun 02 2017 
OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 Jun 01 2017 
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017 May 11 2017 
Merck Collaborates With OncoSec Medical to Unlock Untapped Market for Keytruda May 10 2017 

More From Other Websites
OncoSec Seeks Accelerated Approval to Treat Melanoma Sep 11 2017
OncoSec Appoints Industry Leader Daniel J. O'Connor to its Board of Directors Sep 07 2017
OncoSec Announces Presentations at Upcoming Investment and Scientific Conferences Sep 06 2017
OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors Sep 05 2017
Corporate News Blog - US FDA Approves Portola's Anticoagulant for High-risk Patients with... Jun 27 2017
OncoSec Announces Technology Access Program Agreement with Jounce Therapeutics, Inc. Jun 12 2017
OncoSec Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Unresectable... Jun 08 2017
OncoSec to Present at LD Micro Invitational Jun 02 2017
OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 Jun 01 2017
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017 May 11 2017
OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12... May 10 2017
OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 May 02 2017
OncoSec collaboration data 'promising' for embattled Heat Bio Apr 12 2017
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1 Apr 11 2017
OncoSec Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following... Apr 03 2017
OncoSec to Present Preclinical Data at the American Association for Cancer Research (AACR) Annual... Mar 28 2017
OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness at Enhancing Tumor... Mar 21 2017
OncoSec Announces First Technology Access Program Agreement with Inhibrx Mar 14 2017
OncoSec to Present at Scientific and Investment Conferences in March Mar 07 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}